| Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study TW Geisbert, ACH Lee, M Robbins, JB Geisbert, AN Honko, V Sood, ... The Lancet 375 (9729), 1896-1905, 2010 | 599 | 2010 |
| siRNA and innate immunity M Robbins, A Judge, I MacLachlan Oligonucleotides 19 (2), 89-102, 2009 | 516 | 2009 |
| Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice AD Judge, M Robbins, I Tavakoli, J Levi, L Hu, A Fronda, E Ambegia, ... The Journal of clinical investigation 119 (3), 661-673, 2009 | 454 | 2009 |
| 2′-O-methyl-modified RNAs act as TLR7 antagonists M Robbins, A Judge, L Liang, K McClintock, E Yaworski, I MacLachlan Molecular Therapy 15 (9), 1663-1669, 2007 | 408 | 2007 |
| Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation M Robbins, A Judge, E Ambegia, C Choi, E Yaworski, L Palmer, ... Human gene therapy 19 (10), 991-999, 2008 | 312 | 2008 |
| Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro MA Robbins, M Li, I Leung, H Li, DV Boyer, Y Song, MA Behlke, JJ Rossi Nature biotechnology 24 (5), 566-571, 2006 | 229 | 2006 |
| Compositions and methods for silencing apolipoprotein B ACH Lee, A Judge, M Robbins, E Yaworski, I Maclachlan US Patent 8,236,943, 2012 | 140 | 2012 |
| Compositions and methods for silencing apolipoprotein B ACH Lee, A Judge, M Robbins, E Yaworski, I Maclachlan US Patent 8,236,943, 2012 | 140 | 2012 |
| Compositions and methods for silencing apolipoprotein B ACH Lee, A Judge, M Robbins, E Yaworski, I Maclachlan US Patent 8,236,943, 2012 | 140 | 2012 |
| Compositions and methods for silencing apolipoprotein B ACH Lee, A Judge, M Robbins, E Yaworski, I Maclachlan US Patent 8,236,943, 2012 | 140 | 2012 |
| Molecular aspects of plant virus transmission by olpidium and plasmodiophorid vectors DA Rochon, K Kakani, M Robbins, R Reade Annu. Rev. Phytopathol. 42, 211-241, 2004 | 115 | 2004 |
| Emergent drug resistance with integrase strand transfer inhibitor-based regimens KJ Lepik, PR Harrigan, B Yip, L Wang, MA Robbins, WW Zhang, J Toy, ... Aids 31 (10), 1425-1434, 2017 | 102 | 2017 |
| Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir M Oliveira, RI Ibanescu, K Anstett, T Mésplède, JP Routy, MA Robbins, ... Retrovirology 15, 1-14, 2018 | 97 | 2018 |
| Compositions and methods for silencing ebola virus gene expression TW Geisbert, ACH Lee, M Robbins, V Sood, A Judge, LE Hensley, ... US Patent 9,187,748, 2015 | 86 | 2015 |
| Marburg virus infection in nonhuman primates: therapeutic treatment by lipid-encapsulated siRNA EP Thi, CE Mire, R Ursic-Bedoya, JB Geisbert, AC H. Lee, KN Agans, ... Science translational medicine 6 (250), 250ra116-250ra116, 2014 | 86 | 2014 |
| Sensing the danger in RNA MA Robbins, JJ Rossi Nature medicine 11 (3), 250-251, 2005 | 71 | 2005 |
| Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA EP Thi, ACH Lee, JB Geisbert, R Ursic-Bedoya, KN Agans, M Robbins, ... Nature microbiology 1 (10), 1-10, 2016 | 58 | 2016 |
| Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA R Ursic-Bedoya, CE Mire, M Robbins, JB Geisbert, A Judge, I MacLachlan, ... The Journal of infectious diseases 209 (4), 562-570, 2014 | 54 | 2014 |
| Compositions and methods for silencing ebola virus gene expression TW Geisbert, ACH Lee, M Robbins, V Sood, A Judge, LE Hensley, ... US Patent App. 14/880,082, 2016 | 47 | 2016 |
| Evidence that binding of cucumber necrosis virus to vector zoospores involves recognition of oligosaccharides K Kakani, M Robbins, DA Rochon Journal of Virology 77 (7), 3922-3928, 2003 | 47 | 2003 |
